AVEO Pharmaceuticals, Inc. AVEO
Swinging back around to discuss AVEO is our top order of business this morning after the stock soared to new highs yesterday. We placed this stock on watch on June 23rd, subsequently mentioning it several times.
On the day of our initial alert, AVEO traded for as little as 1.05 per share, and after multiple weeks in a near-contnual uptrend, the gains have been fantastic. Yesterday AVEO reached new four year highs of 3.19, marking an overall swing of 204%
Volume over the same period has been greatly heightened, and yesterday’s close at 3.15 was a strong one, so even though AVEO has had momentum-mover status for several sessions, we’re going to want to continue to watch it closely.
Inotek Pharmaceuticals, Inc. ITEK
We’re always looking for a good bottom-bouncer, which is why we want to take note of ITEK this morning after disappointing study results on the company’s eye drug sent shares tumbling yesterday.
As we point out on the chart snapshot below, the stock has been beaten back into oversold territory, leaving a big gap on the chart. We’ll place it on watch for the filling of that gap, which from present pricing would spell gains of up to 60%
ATNM, HK, FOLD, TEUM, JAGX, MSDI, OCUL